HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 09/06/2012 -- Cleveland BioLabs (NCM:CBLI) is very active today and traded between $1.7402 - 1.96 with total traded volume of 176119 shares. At a current price of 1.92, CBLI is +0.12 - +6.67% from the previous close of $1.80. Moreover, At Current Market Price, CBLI is in distance of +22.16% from its 50-day Moving Average price of $1.5717 and -1.00% from its 200-day Moving Average price of $1.9394.This summer CBLI has signed $4 mln dollar contract with the Ministry of Industry and Trade of the Russian Federation for development of one of CBLI’s drugs, in Putin’s recent effort to invest in tech companies. Putin’s initiative to strengthen Russia’s high-tech sector is not without conditions: companies that accept Russia’s funds must transfer their technologies to Russia and work with local scientists.
click Here To Get MOre Information Click Here
Cross Country Hea (NasdaqNM:CCRN) is +0.39 - +9.54% from the previous close of $4.09. It traded between $4.2695 - 4.89 with total traded volume of 215832 shares. At Current Market Price, CCRN is in distance of +3.43% from its 50-day Moving Average price of $4.3314 and -2.77% from its 200-day Moving Average price of $4.6075. Also showing relative strength are diagnostics shares, up on the day by about 1.7% as a group, led by Cross Country (CCRN), trading higher by about 9.8% . Citi upgraded health services companies Cross Country Healthcare Inc. Cross Country Healthcare was up 9.54% percent at $4.48 per share on volume of 130,000 shares compared to its average daily volume of 92,000 shares. The company has a market cap of $146 million and a 52-week range between $3.76 and $6.73 per share. Citigroup upgraded shares of the company from a neutral rating to a buy rating. Citigroup now has a $7.00 price target on the stock.
Get A Free Copy Today : Click Here
CNO FINANCIAL GRO (NYSE:CNO) reported EPS of 1.444. For the Current Fiscal year, the company is expected to report EPS of 0.74. For the Next Quarter and Next Year, the company is expected to report EPS of 0.20 and 0.84 respectively. At Current Market Price, CNO is in distance of +9.76% from its 50-day Moving Average price of $8.6094 and +22.90% from its 200-day Moving Average price of $7.689.CNO gained 5.5 percent to close at $9.45 in New York. The insurer is seeking $950 million of loans and bonds to repay debt and cut borrowing costs,As part of a repurchase of convertible debentures, CNO’s diluted share count will fall by 36.4 million. CNO plans to obtain senior secured credit consisting of a $400 million, six-year term loan and a $250 million portion that matures in four years, the firm said in yesterday’s statement. CNO also plans to sell $250 million of notes due in 2020 and is seeking a $50 million, three-year revolving credit line.
Need More Outlook About This Stock: Click Here
Conn's, Inc. (NasdaqNM:CONN) is very active today and traded between $24.35 - 26.98 with total traded volume of 1929975 shares. At a current price of 25.89, CONN is +1.94 - +8.10% from the previous close of $23.95. Moreover, At Current Market Price, CONN is in distance of +28.59% from its 50-day Moving Average price of $20.134 and +50.69% from its 200-day Moving Average price of $17.181. The stock was crushed in 2011 on weak sales and big bottom-line losses, but another solid quarter in 2012 -- Conn's swung to a profit of $11.6 million in the second quarter versus a loss of $3.1 million in the year-ago period. Management now sees full-year EPS of $1.40 to $1.50, up from its prior view of $1.30 to $1.40, and expects same-store sales growth of 10% to 15%. "Improvements in our retail operating performance continued into August, when we experienced growth in same store sales of 12% on top of a 6% increase last year," said Chairman and CEO Theodore Wright.
Get The Full Research Report For Free: Click Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)